The impact of Vitamin D Administration on Mortality in COVID-19 Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials

Overview

Journal Inflammopharmacology

Specialty Pharmacology

Date 2024 Sep 3

PMID 39225947

Authors

Chia Siang Kow

Dinesh Sangarran Ramachandram

Syed Shahzad Hasan

Zhiyun Wong

Kaeshaelya Thiruchelvam

Affiliations

Soon will be listed here.

Abstract

Introduction: Vitamin D, known for its role in bone health, is now being explored for its immunomodulatory effects. This study aimed to evaluate the impact of vitamin D supplementation on mortality in coronavirus disease 2019 (COVID-19) patients through a systematic review and meta-analysis of randomized controlled trials.

Methods: A comprehensive search was conducted across PubMed, Scopus, Web of Science, and preprint servers for eligible trials up to July 8, 2024. Two investigators independently screened the records and assessed the risk of bias using the Cochrane Risk of Bias Tool. Trials were eligible if they compared vitamin D with control interventions in adults with COVID-19. Data extraction and analysis were carried out independently, employing a random-effects model to estimate pooled odds ratios for mortality.

Results: Nineteen randomized controlled trials with 2495 participants were included. The meta-analysis showed a significant reduction in all-cause mortality with vitamin D supplementation (pooled OR 0.72, 95% CI 0.53-0.98; I = 20%). Subgroup analysis for severe COVID-19 cases also indicated significant mortality reduction (pooled OR 0.57, 95% CI 0.35-0.92; I = 18%).

Conclusion: Vitamin D supplementation appears to reduce mortality in COVID-19 patients, especially in severe cases. These findings highlight the potential benefits of vitamin D as an adjunct treatment in COVID-19, though further large-scale trials are needed to confirm these effects and determine optimal dosing.

Citing Articles

Herbal and Dietary Supplements as Adjunctive Treatment for Mild SARS-CoV-2 Infection in Italy.

Licata A, Seidita A, Como S, de Carlo G, Cammilleri M, Bonica R Nutrients. 2025; 17(2).

PMID: 39861359 PMC: 11767322. DOI: 10.3390/nu17020230.

The Effect of Vitamin D Supplementation Post COVID-19 Infection and Related Outcomes: A Systematic Review and Meta-Analysis.

Sartini M, Del Puente F, Carbone A, Schinca E, Ottria G, Dupont C Nutrients. 2024; 16(22).

PMID: 39599582 PMC: 11597733. DOI: 10.3390/nu16223794.

The Challenge of Misleading Information: Does the Interaction between Zinc and Vitamin D Influence the Immune Response against SARS-CoV-2 in the Elderly Population?.

Silva D, Moura P, Gopalsamy R, Silva E, Barreto M, Santos R Life (Basel). 2024; 14(10).

PMID: 39459577 PMC: 11509501. DOI: 10.3390/life14101277.

References

Bychinin M, Klypa T, Mandel I, Yusubalieva G, Baklaushev V, Kolyshkina N . Effect of vitamin D3 supplementation on cellular immunity and inflammatory markers in COVID-19 patients admitted to the ICU. Sci Rep. 2022; 12(1):18604. PMC: 9632570. DOI: 10.1038/s41598-022-22045-y. View

Cannata-Andia J, Diaz-Sottolano A, Fernandez P, Palomo-Antequera C, Herrero-Puente P, Mouzo R . A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial. BMC Med. 2022; 20(1):83. PMC: 8853840. DOI: 10.1186/s12916-022-02290-8. View

De Niet S, Tremege M, Coffiner M, Rousseau A, Calmes D, Frix A . Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2022; 14(15). PMC: 9330587. DOI: 10.3390/nu14153048. View

Domazet Bugarin J, Dosenovic S, Ilic D, Delic N, Saric I, Ugrina I . Vitamin D Supplementation and Clinical Outcomes in Severe COVID-19 Patients-Randomized Controlled Trial. Nutrients. 2023; 15(5). PMC: 10005311. DOI: 10.3390/nu15051234. View

Elamir Y, Amir H, Lim S, Rana Y, Lopez C, Viera Feliciano N . A randomized pilot study using calcitriol in hospitalized COVID-19 patients. Bone. 2021; 154:116175. PMC: 8425676. DOI: 10.1016/j.bone.2021.116175. View

Entrenas Castillo M, Entrenas Costa L, Vaquero Barrios J, Alcala Diaz J, Miranda J, Bouillon R . "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study". J Steroid Biochem Mol Biol. 2020; 203:105751. PMC: 7456194. DOI: 10.1016/j.jsbmb.2020.105751. View

Ghaseminejad-Raeini A, Ghaderi A, Sharafi A, Nematollahi-Sani B, Moossavi M, Derakhshani A . Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review. Front Immunol. 2023; 14:950465. PMC: 10379649. DOI: 10.3389/fimmu.2023.950465. View

Jaun F, Boesing M, Luethi-Corridori G, Abig K, Bloch N, Giezendanner S . Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay. Biomedicines. 2023; 11(5). PMC: 10215464. DOI: 10.3390/biomedicines11051277. View

Kalia V, Studzinski G, Sarkar S . Role of vitamin D in regulating COVID-19 severity-An immunological perspective. J Leukoc Biol. 2021; 110(4):809-819. PMC: 8014852. DOI: 10.1002/JLB.4COVR1020-698R. View

10.

Kim D, Meza C, Clarke H, Kim J, Hickner R . Vitamin D and Endothelial Function. Nutrients. 2020; 12(2). PMC: 7071424. DOI: 10.3390/nu12020575. View

11.

Leal-Martinez F, Abarca-Bernal L, Garcia-Perez A, Gonzalez-Tolosa D, Cruz-Cazares G, Montell-Garcia M . Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial. Int J Environ Res Public Health. 2022; 19(3). PMC: 8835093. DOI: 10.3390/ijerph19031172. View

12.

Mariani J, Antonietti L, Tajer C, Ferder L, Inserra F, Sanchez Cunto M . High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial. PLoS One. 2022; 17(5):e0267918. PMC: 9140264. DOI: 10.1371/journal.pone.0267918. View

13.

Meng J, Li X, Liu W, Xiao Y, Tang H, Wu Y . The role of vitamin D in the prevention and treatment of SARS-CoV-2 infection: A meta-analysis of randomized controlled trials. Clin Nutr. 2023; 42(11):2198-2206. DOI: 10.1016/j.clnu.2023.09.008. View

14.

Murai I, Fernandes A, Sales L, Pinto A, Goessler K, Duran C . Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021; 325(11):1053-1060. PMC: 7890452. DOI: 10.1001/jama.2020.26848. View

15.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

16.

Reino-Gelardo S, Palop-Cervera M, Aparisi-Valero N, Espinosa-San Miguel I, Lozano-Rodriguez N, Llop-Furquet G . Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study. Nutrients. 2023; 15(7). PMC: 10096722. DOI: 10.3390/nu15071736. View

17.

Sanz R, Garcia F, Gutierrez A, Garcia Menendez S, Inserra F, Ferder L . Vitamin D3 supplementation in COVID-19 patients with cardiovascular disease and gut dysbiosis. Hipertens Riesgo Vasc. 2024; 41(3):145-153. DOI: 10.1016/j.hipert.2024.04.002. View

18.

Singh A, Rastogi A, Puri G, Ganesh V, Naik N, Kajal K . Therapeutic high-dose vitamin D for vitamin D-deficient severe COVID-19 disease: randomized, double-blind, placebo-controlled study (SHADE-S). J Public Health (Oxf). 2024; 46(2):256-266. DOI: 10.1093/pubmed/fdae007. View

19.

Soliman S, Ghaly M . Ischemic Stroke and Bilateral Pulmonary Embolism in COVID-19: COVID-Associated Coagulopathy or Heparin-Induced Thrombocytopenia. J Hematol. 2022; 11(1):40-44. PMC: 8929198. DOI: 10.14740/jh956. View

20.

Zurita-Cruz J, Fonseca-Tenorio J, Villasis-Keever M, Lopez-Alarcon M, Parra-Ortega I, Lopez-Martinez B . Efficacy and safety of vitamin D supplementation in hospitalized COVID-19 pediatric patients: A randomized controlled trial. Front Pediatr. 2022; 10:943529. PMC: 9357919. DOI: 10.3389/fped.2022.943529. View